Symptomatic bone marrow metastasis in triple-negative breast cancer: a case report and literature review [0.03%]
三阴性乳腺癌骨髓转移一例并文献复习
Chenhui Zheng,Jingjing Dai,Yu Wang et al.
Chenhui Zheng et al.
Bone metastasis is common in breast cancer, but symptomatic bone marrow involvement is exceedingly rare. This report presents a case of a young female patient with triple-negative breast cancer (TNBC) initially presenting with symptomatic b...
Forecasting cancer incidence and prevalence using age-period-cohort and survivorship models: a practical, flexible, and interpretable framework [0.03%]
基于年龄-时期-队列和幸存者模型的癌症发病和患病率预测：一种实用、灵活且可解释的框架
Ana F Best,Adalberto M Filho,Philip S Rosenberg
Ana F Best
Age-period-cohort (APC) model outputs have been used extensively to produce forecasts of cancer incidence, identify emerging public health concerns, and quantify the impact of potential interventions. However, these models have not been ext...
Case Report: Personalized diagnosis and treatment strategies for three cases of cancer of unknown primary based on molecular testing techniques [0.03%]
基于分子检测技术的三例原发不明肿瘤的诊疗体会
Yao Ding,Kexue Zhou,Kaiwen Fu et al.
Yao Ding et al.
Cancer of unknown primary (CUP) is a malignancy characterized by metastatic disease at diagnosis with an unidentified primary site, accounting for 3-5% of all cancers. Despite significant advancements in cancer diagnosis and treatment in re...
Cutaneous histiocytic sarcoma arising from soft tissue filler injections: a case report [0.03%]
关于填充剂注射诱发的皮肤组织细胞肉瘤一例报告
Jangyoun Choi,Heeyang Park,Eun Jeong Ko et al.
Jangyoun Choi et al.
Background: The administration of soft-tissue fillers is a popular aesthetic procedure. Nonetheless, it can result in complications such as foreign-body reactions, infections, skin necrosis, granulomas, and even malignant...
TAS-102 in combination with bevacizumab for second-line treatment of metastatic colorectal cancer with a hypertensive elderly patient: a case report [0.03%]
TAS-102联合贝伐单抗治疗老年高血压患者晚期结直肠癌的二线治疗：一例报告
Lingling Xu,Xun Qiu,Hongmei He et al.
Lingling Xu et al.
Background: Colorectal cancer (CRC) is a common malignant tumor worldwide. Approximately 20%-25% of patients have metastases at the time of initial diagnosis, and nearly half eventually develop metastatic cancer. The stan...
Obesity, overweight and breast cancer: new clinical data and implications for practice [0.03%]
肥胖、体重过重与乳腺癌：新的临床数据及其对实践的启示
Laura García-Estévez,Marta González-Rodríguez,Isabel Calvo et al.
Laura García-Estévez et al.
Excess bodyweight has negative consequences in breast cancer (BC) patients, significantly increasing the incidence of BC and adversely affecting clinical outcomes in most BC subtypes. This article overviews recent evidence relating to exces...
Editorial: Immunotherapy: up to date progress in childhood and hematological malignancies [0.03%]
免疫治疗在儿童及血液系统恶性肿瘤中的最新进展
Kishore B Challagundla,Kausar M Ansari,Manoj K Pandey
Kishore B Challagundla
Maria S Infante,José-Angel Hernández-Rivas
Maria S Infante
Case Report: Decitabine and venetoclax sequentially followed by FLAG-Ida and venetoclax with immediate allogeneic stem cell transplantation in newly diagnosed acute myeloid leukemia with chromosome 3 inversion/ MECOM rearrangement [0.03%]
病例报告：_DECITABINE和VENETOCLAX序贯治疗后予以FLAG-IDA+VENETOCLAX联合立即allo-HSCT治疗t（3；）/MECOM重排的初诊急性髓系白血病患者
Andrius Žučenka,Milvydė Tamutytė
Andrius Žučenka
The prognosis of MECOMr AML is poor, with a 5-year overall survival (OS) rate of less than 10%. This is mostly attributable to the low efficacy of all available therapies and high relapse rates even after allogeneic stem cell transplantatio...
Haotian Li,Junhan Li,Yue Zhang et al.
Haotian Li et al.
Cancer is a disease where cells begin to divide uncontrollably and spread to other parts of the body. Mitotic kinases play a crucial role in the initiation and progression of all human malignancies, making them common therapeutic targets. H...